University Hospitals Primary Care Institute 2026 Wellness Symposium

Continuing Medical Education

Presented by:

Sponsored by:

Saturday, February 28, 2026
7:30 a.m. – 12 p.m.

Corporate College East
4400 Richmond Road
Warrensville Heights, Ohio 44128

Educational Design and Methodology

The program will consist of didactic lectures followed by a question and answer session and panel discussion.

Learning Objectives 

• After attending this program, participants will be able to: 
• Recognize the more common neurodegenerative disorders and identify the diagnostic evaluative criteria.
• Discuss the current treatment management for Neurodegenerative disorders.
• List the upcoming initiatives expected in the Epic software that will be available at UH.
• Identify the industry trends that Epic responds to when developing new software.
• Explain the mechanisms, benefits, and safety profiles of GLP-1 receptor agonists to make confident, evidence-based prescribing decisions.
• Summarize individual medication and the labeled indications by highlighting what we need to address for insurance coverage and alternative ways to get the medications without coverage (cash prices, manufacturer programs, etc).
• Review key recommendations from major COPD clinical practice guidelines.
• Translate guideline-based recommendations into practical workflows.
• Present ongoing COPD quality improvement initiatives at our institution.

Who Should Attend

This event is designed for health care providers of primary care services, including physicians, nurse practitioners and physician assistants (APPs). Residents and students may also find this education of value. 

Registration

Visit https://cwru.cloud-cme.com/UHWELLNESS26 with your credit card, through February 28. 
Physician: $50 | Non-Physician/Residents/Fellows: $25 | No refunds.

Continuing Education

Physicians 
Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Case Western Reserve University School of Medicine designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending. 

Nurses and Physician Assistants
The American Nurses Credentialing Center (ANCC) and the American Academy of Physician Assistants (AAPA) accept AMA PRA Category 1 Credits^TM toward recertification requirements. 

Credits
AMA PRA Category 1 Credits™ (3.75 hours), Non-Physician Attendance (3.75 hours)

Agenda

7:30-7:50 a.m. | Registration and Continental Breakfast

7:50-8 a.m. | Welcome and Introductions
George Topalsky, MD, FACP 

8-8:30 a.m. | Research at UH – Bringing Hope to Patients
Daniel Spratt, MD

8:30-9 a.m. | Neurodegenerative Disorders and their Management
Philipp Dines, MD, PhD

9 -9:45 a.m. | Keynote Presentation: Epic Development Trends and Future Views 
Jordan Marschke-Kemp

9:45-10 a.m. | Break

10-10:30 a.m. | A Potpourri of Osteoporosis: Insights and Updates
Marina Nighat Magrey, MD

10:30-11a.m. | Prescribe GLP1 Receptor Agonists with Confidence
Erica Reinhart

11-11:30 a.m. | From Evidence to Action: Implementing COPD Clinical Practice Guidelines in Everyday Care
Jihane Faress, MD

11:30-12 p.m. | Panel Discussion/Questions and Answer Session

12 p.m. | Conference Adjourns

Speakers

Keynote Speaker

Jordan Marschke-Kemp
Project Manager, Epic

Faculty

Philipp Dines, MD
Program Director, Geriatric Psychiatry, UH Cleveland Medical Center
Medical Director and Chief, Geriatric Psychiatry, UH Cleveland Medical Center
Associate Professor, Case Western Reserve University School of Medicine

Jihane Faress, MD, PhD
Co-Chair, DOM QA Committee, UH Cleveland Medical Center
Assistant Professor, Case Western Reserve University School of Medicine

Marina Nighat Magrey, MD
Division Chief, Rheumatology, UH Cleveland Medical Center
Professor, Case Western Reserve University School of Medicine

Erica Reinhart
Supervisor, UH Pharmacy

Daniel Spratt, MD
Chair, Department of Radiation Oncology, UH Cleveland Medical Center
Professor, Case Western Reserve University School of Medicine
Vincent K. Smith Chair in Radiation Oncology, UH Seidman Cancer Center
UH Clinical Research Center Medical Director and Associate Chief Scientific Officer

George Topalsky, MD, FACP 
President, UH Medical Practices,
University Hospitals Primary Care Institute

Faculty Disclosure

As an organization accredited by the ACCME, the Case Western Reserve University School of Medicine CME Program requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. All faculty, planners, and others in a position to control continuing medical education content are required to disclose all financial relationships with ineligible companies within the past 24 months regardless of the amount and their view of the relevance of the relationship to the education. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Faculty (authors, presenters, speakers) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality. The Case Western Reserve University School of Medicine CME Program has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants are asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity.